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CC BY-NC-ND license (http://creativeAbstract Osteoarthritis (OA) is the most common form of joint disease and the leading cause
of chronic disability in middle-aged and older populations. The development of disease-
modifying therapy for OA currently faces major obstacles largely because the regulatory mech-
anisms for the function of joint tissue cells remain unclear. Previous studies have found that
the alterations in gene expression of specific transcription factors (TFs), pro- or anti-
inflammatory cytokines, matrix proteinases and extracellular matrix (ECM) proteins in articular
cartilage may be involved in the development of OA. However, the regulatory mechanisms for
the expression of those genes in OA chondrocytes are largely unknown. The recent advances in
epigenetic studies have shed light on the importance of epigenetic regulation of gene expres-
sion in the development of OA. In this review, we summarize and discuss the recent studies on
the regulatory roles of various epigenetic mechanisms in the expression of genes for specific
TFs, cytokines, ECM proteins and matrix proteinases, as well the significance of these epige-
netic mechanisms in the pathogenesis of OA.
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Osteoarthritis (OA) is the most common form of arthritis in
the U.S. and affects approximately 27 million Americans.1
As OA mainly occurs in weight-bearing joints, such as the
knee and hip, OA has long been thought of as a mechanical
issue.2 However, there is a growing body of evidence sup-
porting the notion that OA is a result of the interaction
between mechanical and molecular events in the affected
joint.3 There is no single specific cause that has beenand hosting by Elsevier B.V. This is an open access article under the
4.0/).
70 M. Zhang, J. Wangidentified for OA to date. Some risk factors, including age,
gender, obesity, joint injury, genetic and mechanical ab-
normalities, have been shown to be associated with the
development of OA.4 However, how these risk factors
trigger the onset of OA still need to be elucidated. While OA
is a disease of the whole joint and may affect all of the
joint tissues, articular cartilage degradation is a major
hallmark of OA.5 Aberrant gene expression of specific
transcription factors (TFs), cytokines, matrix proteinases
and extracellular matrix (ECM) structural proteins (e.g.,
collagens and proteoglycans) in articular chondrocytes
(ACs) of human OA and animal models of OA samples has
been documented. Nevertheless, the underlying regulatory
mechanism for the expression of those genes in OA carti-
lage is not fully understood.
“Epigenetics” is referred to as changes in gene expres-
sion caused by mechanisms other than changes in the un-
derlying DNA sequences. DNA methylation and histone
modification are the two best-studied classic epigenetic
regulatory mechanisms, which regulate the transcriptional
activity of a cell in the nucleus. DNA methylation is a
biochemical process where a methyl group is added to the
cytosine or adenine, mainly at the C5 position of CpG di-
nucleotides, by DNA methyltransferase (DNMT). DNA
hypermethylation suppresses gene transcription, while DNA
hypomethylation enhances gene transcription. Histone
modifications are enzymatic post-translational modifica-
tions which include methylation, acetylation, phosphory-
lation, sumoylation and ubiquitination.6,7 These
modifications primarily occur within the amino-terminal
tails of histone proteins that regulate gene expression by
changing the chromatin structure.8
A broader definition of “epigenetics” has been proposed
by Egger et al as heritable changes in gene expression that
are not coded in the DNA sequences.9 In this regard, non-
coding RNAs (ncRNAs) which possess epigenetic-like prop-
erties have also been taken into account as one of the
epigenetic mechanisms.10,11 ncRNAs are functional RNA
molecules that regulate gene expression but do not trans-
late into proteins. ncRNAs can be mainly divided into short
ncRNAs (<30 nucleotides) and long ncRNAs (lncRNAs, >200
nucleotides). Short ncRNAs include microRNAs (miRNAs),
short interfering RNAs (siRNAs) and piwi-interacting RNAsTable 1 Gene expression changes mediated by epigenetic mec
Category Gene Expressiona Epigenetic reg
DNA methylat
TFs Nfat1 Y (m) 4
SOX9 Y (h) U
Cytokines IL-1B [ (h) U
TNF-alpha [ (h) 4
Proteinases ADAMTS4 [ (h) U
ADAMTS5 [ (h) U
MMP-13 [ (h) U
ECM proteins COL2A1 Y (h) 4
COL9A1 Y (h) U
ACAN Y (h) 7
a Gene expression information is cited from the references of this m
b Gene expression changes are associated with specific epigenetic a(piRNAs).12 In general, miRNAs function to modify the pro-
tein expression mainly at the post-transcriptional level in
cytoplasm by binding to a specific target messenger RNA
(mRNA) with a complimentary sequence to induce cleav-
age, degradation or block translation.13 Recent progress in
the study of ncRNAs has revealed the importance of ncRNAs
in development and diseases.14,15
Given the importance of epigenetics in normal devel-
opment as well as cancer and age-related diseases,11
recent studies on epigenetics in OA have provided new in-
sights into the pathogenesis of OA and new targets to
develop potential therapeutic strategies for OA. In this
review, we will focus on the epigenetic mechanisms for the
expression of TFs, cytokines, matrix proteinases and ECM
proteins in ACs, as well as their significance in the patho-
genesis of OA (Table 1).TFs
TFs are the proteins that bind to specific DNA sequences
and control the transcriptional rate of the target genes
from genomic DNA to mRNA, which then translate into
protein in the cytoplasm. Therefore, abnormal expression
of TFs has been found to be involved in the development of
many diseases, including OA.
Nfat1 (NFAT1/NFATc2) is a member of the Nuclear Factor
of Activated T-cells (NFAT) transcription factor family
originally identified as a regulator of the expression of
cytokine genes during the immune response.34,35 NFAT1 has
recently been shown to play an important role in main-
taining the permanent cartilage phenotype in adult mice.
Nfat1 knockout (Nfat1/) mice exhibit normal skeletal
development, but display over-expression of numerous
matrix-degrading proteinases and proinflammatory cyto-
kines and loss of collagen-2 and aggrecan during the initi-
ation stage of OA. These initial changes are followed by
articular chondrocyte clustering, formation of chondro-
osteophytes, progressive articular surface destruction,
formation of subchondral bone cysts, and exposure of
thickened subchondral bone.16
Our recent studies have demonstrated that NFAT1 reg-
ulates the chondrocyte function through its age-dependenthanisms in osteoarthritic chondrocytes.
ulationb References
ion Histone modification microRNA
U 4 16,17
U U 18e20
4 U 21e23
4 U 23
U U 24e27
U U 20,26,27
U U 24,27,28
U U 20,29e31
4 4 32
U U 20,33
anuscript. Y: decrease; [: increase; m: mouse; h: human.
lterations (U), or not (7), or unknown (4).
Epigenetics and osteoarthritis 71expression in mouse articular cartilage. NFAT1 expression in
wild-type articular chondrocytes was low in the embryonic,
but high in the adult stage (2e6 months old). Our epige-
netic studies17 revealed that an increase in NFAT1 expres-
sion in ACs is associated with increased H3K4me2 (a histone
modification linked to transcriptional activation); while a
decrease in NFAT1 expression in ACs is correlated with
increased H3K9me2 (a histone modification linked to tran-
scriptional repression). Knockdown of lysine-specific
demethylase-1 (Lsd1) in embryonic ACs up-regulates
NFAT1 expression concomitant with increased H3K4me2 at
the Nfat1 promoter. Knockdown of Jmjc-containing histone
demethylase-2a (Jhdm2a) in 6-month ACs down-regulates
NFAT1 expression concomitant with increased H3K9me2 at
the Nfat1 promoter. These results suggest that the age-
dependent NFAT1 expression in ACs is regulated by dy-
namic histone methylation.17 Further study should be
directed to investigate the expression of NFAT1 in aged
articular cartilage and its underlying epigenetic mecha-
nisms as well as the role of NFAT1 in the development of OA
in humans.
SOX9 is a master transcription factor for chondrogenesis
during the development of the skeletal system, in cooper-
ation with SOX5 and SOX6.36,37 Although mice with condi-
tional postnatal deletion of Sox9 in articular cartilage did not
develop OA even by the age of 18 months,38 later OA usually
is associated with decreased SOX9 expression in humans.39
Kim et al recently reported that down-regulated SOX9
expression in advanced hip OA chondrocytes is mediated by
DNAmethylation and histonemodification, including histone
methylation and acetylation.18 Moreover, miRNA-145 has
been identified as an inhibitor of SOX9 expression in human
chondrocyte; increased miRNA-145 directly represses SOX9
expression, causing reduced expression of COL2A1 and
aggrecan and an increased level of matrix metal-
loproteinases 13 (MMP13).19 In addition, miRNA-199a-3p and
miRNA-193b has been found to down-regulate SOX9
expression.20 While SOX9 is considered a typical anabolic
factor in articular cartilage, the response of cultured chon-
drocytes to forced expression of SOX9 has been controver-
sial. Kypriotou et al found that overexpression of SOX9 itself
was unable to restore the chondrocyte phenotype in dedif-
ferentiated osteoarthritic chondrocytes,40 whereas Cuc-
chiarini et al reported that r-AAV mediated SOX9 gene
transfer up-regulated the expression levels of proteoglycans
and type II collagen in normal and OA ACs.41 Therefore, more
studies are needed to determine whether the epigenetically
regulated change in SOX9 expression in articular cartilage is
the cause or the result of OA.Cytokines
Cytokines are small proteins mostly secreted by immune
cells that function as signaling messengers in the immune
system. It has been well-documented that cytokines play
important roles in the development of rheumatoid arthritis
(RA) which is a typical autoimmune disease in human
joints.42 A new concept that OA is a joint disease of
inflammation involving immune reaction has been proposed
based on findings of the aberrant expression of cytokines in
human OA and animal models of OA.43 Although manycytokines have been implicated in OA, interlukin 1-b (IL-1b)
and tumor necrosis factor-a (TNF-a) are the two main
proinflammatory cytokines contributing to the degradation
of articular cartilage.44,45
The epigenetic regulation of IL-1b expression in OA
cartilage has been well documented. Hashimoto et al
found that specific CpG sites at 299 of the IL-1b promoter
has a significant impact on its promoter activity and
methylation of these sites results in marked suppression of
its transcriptional activity in human ACs.21 Demethylation
of these sites increases the transcriptional response of IL-
1b to inflammatory cytokines in human ACs.22 In addition,
Santini et al found miR-149 is down-regulated in OA
chondrocytes, and a functional study showed that this
miRNA regulates the production of TNF-a, IL-1b and IL-6.23
Other than being regulated by epigenetic mechanisms, IL-
1b also modulates epigenetic events in OA cartilage,
because stimulation of OA chondrocytes with IL-1b can
affect miRNA production.46 Moreover, the overall methyl-
ation status in different histological zones of human
cartilage was found to be different upon IL-1b stimula-
tion.47 Both DNA methylation and histone modification are
involved in the control of TNF-a expression48; however,
the epigenetic status of TNF-a in OA chondrocytes remains
to be elucidated.Matrix proteinases
The expression of matrix proteinases, including collage-
nases, aggrecanases and matrix metalloproteinases (MMPs),
is relatively low in normal articular cartilage. Matrix pro-
teinases are required for cartilage turnover but elevated in
OA, which are deleterious factors for ECM degradation.49,50
ADAMTS (a disintegrin and metalloproteinase with throm-
bospondin motifs) -4 and -5 are two major aggrecanases
which have been shown to play important role in develop-
ment of OA.51e54 MMP13, a major type II collagen-degrading
collagenase, not only contributes to the onset of OA, but
also contributes to irreversible joint damage during the
progression of OA.55,56 In addition to being regulated by
transcription factors and cytokines, proteinase expression
is also regulated by DNA methylation.24 For example,
Cheung et al found that increased ADAMTS-4 expression was
mediated by the loss of DNA methylation at specific CpG
sites in the ADAMTS-4 promoter in OA chondrocytes.25 In OA
cartilage specifically, differentially and highly expressed
lncRNA-CIR not only controls the expression of collagen and
aggrecan but also regulates the expression of MMP13 and
ADAMTS-5.26 Moreover, several miRNAs have also been
found to regulate ADAMTS-5 expression in human OA
cartilage.20 In a study of cultured SW1353 chondrosarcoma
cells and primary human chondrocytes, Young et al
demonstrated that histone deacetylase (HDAC) inhibitors
decreased the level of collagenolytic enzymes in condi-
tioned culture medium by down-regulating the expression
of MMPs and ADAMTSs, and the elevated HDAC7 expression
in cartilage from OA patients was associated with up-
regulated MMP13 gene expression,28 implicating that his-
tone modification, especially acetylation, may play a role in
the control of those proteinases in the pathogenesis of
OA.27
72 M. Zhang, J. WangExtracellular matrix proteins
Collagen and proteoglycan are the major ECM protein
components of articular cartilage. The maintenance of the
normal amount and architecture of these components are
required for articular cartilage to fulfill its mechanical
properties.57,58 In humans, collagen gene mutations ac-
count for a family of spondyloepiphyseal dysplasias, which
are associated with early-onset of OA.59 Mice that lack
Col9a1 or bear a small deletion mutation in type II collagen
gene display OA-like cartilage degradation.60,61 Adult
articular cartilage is an avascular tissue, in which chon-
drocytes, the unique cellular component, do not normally
divide, but maintain low-turnover replacement of the ECM.
Therefore, degeneration of articular cartilage ECM is the
major feature of OA.49,62 As discussed above, the up-
regulated matrix proteinases contribute to ECM disrup-
tion. Decreased ECM synthesis activity of chondrocytes
regulated by epigenetic mechanisms accounts for the loss
of ECM in OA cartilage.ArƟcular carƟ
degeneraƟ
OA
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Figure 1 Possible roles of epigenetic changes in the pathogenes
drocytes undergo epigenetic events including DNA methylation an
which function in the cytoplasm. This results in aberrant expression
Abnormal expression of these factors may disrupt the balance of
meostasis, leading to articular cartilage degradation and the deveHistone acetyl-transferase CBP/P300 and the Class III
NAD-dependent histone deacetylase Sirtuin 1 (SirT1) have
been shown to co-regulate COL2A1 mRNA expression in
cooperation with SOX9.29,30 Moreover, a recent study using
human chondrocytes found that histone methyltransferase
Set7/9 elevated trimethylated lysine 4 on histone 3 on
COL2A1 promoter, resulting in increased COL2A1 expres-
sion.31 In a study on the correlation between gene
methylation and expression of aggrecan in chondrocytes,
Pochl et al failed to find a significant correlation of ACAN
mRNA expression levels and DNA methylation status be-
tween normal aged and osteoarthritic chondrocytes. This
result suggests that DNA methylation does not play a cen-
tral role in switching off ACAN promoter activity in human
adult ACs.33 Although the methylation status of COL2A1 has
been studied in differentiated and dedifferentiated chon-
drocytes,63 little is known about the role of DNA methyl-
ation in COL2A1 expression in OA chondrocytes. DNA
methylation has also been found to control the decreased
expression of COL9A1 mRNA in OA chondrocytes. Imagawalage 
on
s 
obesity, injury, 
maliƟes)
xpression 
n, aggrecan, 
ases) 
Cytoplasm
hanisms
is of OA. Under the accumulative effect of risk factors, chon-
d histone modifications that occur in the nucleus, and miRNAs
of TFs, cytokines, collagen, aggrecan, and matrix proteinases.
anabolic and catabolic activity and compromise cartilage ho-
lopment of OA.
Epigenetics and osteoarthritis 73et al recently reported that CpG sites in COL9A1 promoter
were hypermethylated and that this hypermethylated CpG
attenuated SOX9 binding to the COL9A1 promoter, resulting
in down-regulation of COL9A1 expression in OA cartilage.32
In addition to the regulation of SOX9 expression, miRNA-
199a-3p and miRNA-193b also control the expression of
COL2A1 and aggrecan in human OA chondrocytes.20Conclusions and future directions
As epigenetics is a molecular link of environmental factors
to the development of diseases,64,65 the advance of epi-
genetics has greatly enhanced our understanding of the
pathogenesis of multifactorial diseases, such as cancer and
OA. Accumulative influence of risk factors which trigger
epigenetic events such as DNA methylation, histone modi-
fications and miRNAs in chondrocytes, may result in aber-
rant gene expression of TFs, cytokines, collagen and
aggrecan, and matrix proteinases. Abnormal expression of
these genes may compromise the balance of anabolic and
catabolic activity and disrupt cartilage homeostasis, lead-
ing to cartilage degradation, which is the key step of the
development of OA (Fig. 1). Moreover, the formation of
positive feedback loops among TFs, cytokines and matrix
proteinases during the development of OA may partially
explain why OA is irreversible once occurs.66
With the use of new techniques, especially the appli-
cation of second generation sequencing in the study of
epigenetics, the era of epigenetic study in the pathogenesis
of OA is coming.67 Global analysis of epigenetic modifica-
tions in OA is being undertaken and more detailed epige-
netic alterations in OA will be identified.47,68e70 The
upcoming epigenetic findings may not only broaden our
knowledge to appreciate the molecular mechanisms un-
derlying the development of OA, but also promote the
development of new drugs for the treatment of OA.71Conflicts of interest
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